This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (25)  • Contact me when this article is cited  Related Content  • Related letter  • Similar articles in this journal  Topic Collections  • Aging/ Geriatrics  • Nutritional and Metabolic Disorders  • Nutrition/ Malnutrition  • Quality of Care  • Evidence-Based Medicine  • Surgery  • Surgical Interventions  • Orthopedic Surgery  • Drug Therapy  • Drug Therapy, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

A Meta-analysis of Randomized Controlled Trials

Heike A. Bischoff-Ferrari, DrPH; Walter C. Willett, DrPH; John B. Wong, MD; Andreas E. Stuck, MD; Hannes B. Staehelin, MD; E. John Orav, PhD; Anna Thoma, MD; Douglas P. Kiel, MD; Jana Henschkowski, MD

Arch Intern Med. 2009;169(6):551-561.

Background  Antifracture efficacy with supplemental vitamin D has been questioned by recent trials.

Methods  We performed a meta-analysis on the efficacy of oral supplemental vitamin D in preventing nonvertebral and hip fractures among older individuals (65 years). We included 12 double-blind randomized controlled trials (RCTs) for nonvertebral fractures (n = 42 279) and 8 RCTs for hip fractures (n = 40 886) comparing oral vitamin D, with or without calcium, with calcium or placebo. To incorporate adherence to treatment, we multiplied the dose by the percentage of adherence to estimate the mean received dose (dose x adherence) for each trial.

Results  The pooled relative risk (RR) was 0.86 (95% confidence interval [CI], 0.77-0.96) for prevention of nonvertebral fractures and 0.91 (95% CI, 0.78-1.05) for the prevention of hip fractures, but with significant heterogeneity for both end points. Including all trials, antifracture efficacy increased significantly with a higher dose and higher achieved blood 25-hydroxyvitamin D levels for both end points. Consistently, pooling trials with a higher received dose of more than 400 IU/d resolved heterogeneity. For the higher dose, the pooled RR was 0.80 (95% CI, 0.72-0.89; n = 33 265 subjects from 9 trials) for nonvertebral fractures and 0.82 (95% CI, 0.69-0.97; n = 31 872 subjects from 5 trials) for hip fractures. The higher dose reduced nonvertebral fractures in community-dwelling individuals (–29%) and institutionalized older individuals (–15%), and its effect was independent of additional calcium supplementation.

Conclusion  Nonvertebral fracture prevention with vitamin D is dose dependent, and a higher dose should reduce fractures by at least 20% for individuals aged 65 years or older.

Author Affiliations: Center on Aging and Mobility (Drs Bischoff-Ferrari and Henschkowski) and Department of Rheumatology and Institute of Physical Medicine (Drs Bischoff-Ferrari and Thoma), University of Zurich, University Hospital, Zurich, Switzerland; Departments of Nutrition (Drs Bischoff-Ferrari and Willett) and Biostatistics (Dr Orav), Harvard School of Public Health, Boston, Massachusetts; Division of Clinical Decision Making, Tufts Medical Center, Boston (Dr Wong); Department of Geriatrics and Rehabilitation, Zieglerspital, University of Bern, Bern, Switzerland (Drs Stuck and Henschkowski); Department of Geriatrics, University Hospital Basel, Basel, Switzerland (Dr Staehelin); and Division on Aging, Harvard Medical School, Boston (Dr Kiel).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED LETTER

Relationship Between Bone, Fracture, and Exercise: The Key Role of Vitamin D
Cédric Annweiler and Olivier Beauchet
Arch Intern Med. 2009;169(17):1638.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Update in Vitamin D
Adams and Hewison
J. Clin. Endocrinol. Metab. 2010;95:471-478.
ABSTRACT | FULL TEXT  

Association between pre-diagnostic circulating vitamin D concentration and risk of colorectal cancer in European populations:a nested case-control study
Jenab et al.
BMJ 2010;340:b5500-b5500.
ABSTRACT | FULL TEXT  

The Patient Who Falls: "It's Always a Trade-off"
Tinetti and Kumar
JAMA 2010;303:258-266.
ABSTRACT | FULL TEXT  

Reducing the risk of fractures with calcium and vitamin D
Sahota
BMJ 2010;340:b5492-b5492.
FULL TEXT  

Vitamin D insufficiency and health outcomes over 5 y in older women
Bolland et al.
Am. J. Clin. Nutr. 2010;91:82-89.
ABSTRACT | FULL TEXT  

Serum 25(OH)D3 vitamin status of elderly Finnish women is suboptimal even after summer sunshine but is not associated with bone density or turnover
Pekkarinen et al.
Eur J Endocrinol 2010;162:183-189.
ABSTRACT | FULL TEXT  

Medical Care for the Final Years of Life: "When You're 83, It's Not Going to Be 20 Years"
Reuben
JAMA 2009;302:2686-2694.
ABSTRACT | FULL TEXT  

Update: A 55-Year-Old Woman With Osteopenia
Mattson-DiCecca et al.
JAMA 2009;302:2023-2024.
FULL TEXT  

Vitamin D: An Evidence-Based Review
Kulie et al.
J Am Board Fam Med 2009;22:698-706.
ABSTRACT | FULL TEXT  

Osteoporosis Disease Management: What Every Orthopaedic Surgeon Should Know
Dell et al.
JBJS 2009;91:79-86.
FULL TEXT  

Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials
Bischoff-Ferrari et al.
BMJ 2009;339:b3692-b3692.
ABSTRACT | FULL TEXT  

Relationship Between Bone, Fracture, and Exercise: The Key Role of Vitamin D
Annweiler and Beauchet
Arch Intern Med 2009;169:1638-1638.
FULL TEXT  

Relationship Between Bone, Fracture, and Exercise: The Key Role of Vitamin D--Reply
Bischoff-Ferrari et al.
Arch Intern Med 2009;169:1638-1638.
FULL TEXT  

Epidemiology of Vitamin D Insufficiency and Cancer Mortality
PILZ et al.
Anticancer Res 2009;29:3699-3704.
ABSTRACT | FULL TEXT